Showing 49 to 60 of 92 results
AlphaFold Revolutionizes Drug Discovery
AlphaFold, a DeepMind AI, predicts protein 3D structures in minutes, accelerating drug discovery and research; its database of 250 million structures has been used by almost 2 million researchers, leading to discoveries like a new liver cancer drug and a molecular syringe.
AlphaFold Revolutionizes Drug Discovery
AlphaFold, a DeepMind AI, predicts protein 3D structures in minutes, accelerating drug discovery and research; its database of 250 million structures has been used by almost 2 million researchers, leading to discoveries like a new liver cancer drug and a molecular syringe.
Progress
48% Bias Score
23andMe Files for Bankruptcy, Raising Genetic Data Privacy Concerns
23andMe, a genetic testing company, filed for Chapter 11 bankruptcy, raising concerns about the privacy of over 15 million consumers' genetic data, which is not protected by HIPAA, despite 80% opting into research. The company plans to continue operations during a sale process.
23andMe Files for Bankruptcy, Raising Genetic Data Privacy Concerns
23andMe, a genetic testing company, filed for Chapter 11 bankruptcy, raising concerns about the privacy of over 15 million consumers' genetic data, which is not protected by HIPAA, despite 80% opting into research. The company plans to continue operations during a sale process.
Progress
52% Bias Score
Massive Hadal Microorganism Discovery Expands Understanding of Marine Biodiversity
A Chinese research team, using the Fendouzhe submersible, discovered 7,564 prokaryotic microorganisms (89.4% previously unknown) in the hadal zone during an expedition from October to December 2021, significantly expanding our understanding of marine microbial diversity and offering potential breakt...
Massive Hadal Microorganism Discovery Expands Understanding of Marine Biodiversity
A Chinese research team, using the Fendouzhe submersible, discovered 7,564 prokaryotic microorganisms (89.4% previously unknown) in the hadal zone during an expedition from October to December 2021, significantly expanding our understanding of marine microbial diversity and offering potential breakt...
Progress
20% Bias Score
Mixed Results in Private Space Exploration: Odin Fails, Blue Ghost and Athena Land
AstroForge's Odin spacecraft failed during its asteroid-mining mission, while Firefly Aerospace's Blue Ghost lunar lander successfully landed and began operations, and Intuitive Machines' Athena lander landed but malfunctioned, ending its mission prematurely.
Mixed Results in Private Space Exploration: Odin Fails, Blue Ghost and Athena Land
AstroForge's Odin spacecraft failed during its asteroid-mining mission, while Firefly Aerospace's Blue Ghost lunar lander successfully landed and began operations, and Intuitive Machines' Athena lander landed but malfunctioned, ending its mission prematurely.
Progress
40% Bias Score
Gene-Edited Mice: A Step Towards Woolly Mammoth De-Extinction
Colossal Biosciences announced it successfully edited 7 genes in mice to give them a woolly mammoth-like coat and fat layer, a step towards their goal of de-extincting woolly mammoths using CRISPR technology and an artificial womb, raising ethical and ecological concerns.
Gene-Edited Mice: A Step Towards Woolly Mammoth De-Extinction
Colossal Biosciences announced it successfully edited 7 genes in mice to give them a woolly mammoth-like coat and fat layer, a step towards their goal of de-extincting woolly mammoths using CRISPR technology and an artificial womb, raising ethical and ecological concerns.
Progress
64% Bias Score
AI-Driven Health Tech Attracts Billions in Investment, Fueling Greek Startup Growth
Investors poured over \$7.5 billion into AI-powered health tech in 2022, with 2023 showing continued growth; Greek startups like Achira.ai, Deepure, and PolyModels Hub are key players in this trend, attracting significant funding and contributing to faster drug discovery.
AI-Driven Health Tech Attracts Billions in Investment, Fueling Greek Startup Growth
Investors poured over \$7.5 billion into AI-powered health tech in 2022, with 2023 showing continued growth; Greek startups like Achira.ai, Deepure, and PolyModels Hub are key players in this trend, attracting significant funding and contributing to faster drug discovery.
Progress
44% Bias Score
AI Revolutionizes Protein Design: Shanghai Breakthrough Cuts Modification Time
Shanghai scientists created the world's largest protein sequence database, Venus-Pod (9 billion sequences), and AI models (Venus series) to drastically reduce protein modification time from years to months, impacting various industries.
AI Revolutionizes Protein Design: Shanghai Breakthrough Cuts Modification Time
Shanghai scientists created the world's largest protein sequence database, Venus-Pod (9 billion sequences), and AI models (Venus series) to drastically reduce protein modification time from years to months, impacting various industries.
Progress
36% Bias Score
AstraZeneca Invests $2.5 Billion in Beijing R&D Center
AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.
AstraZeneca Invests $2.5 Billion in Beijing R&D Center
AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global R&D center, partnering with three Chinese biotech companies and the Beijing Cancer Hospital, aiming to leverage China's life sciences ecosystem and expand its global reach.
Progress
52% Bias Score
EU Approves Less Stringent GMO Regulations
EU member states approved a compromise on less stringent genetic engineering regulations, reducing hurdles for research and sales of genetically modified plants and potentially relaxing labeling requirements; this decision, however, allows individual states to ban the cultivation of significantly mo...
EU Approves Less Stringent GMO Regulations
EU member states approved a compromise on less stringent genetic engineering regulations, reducing hurdles for research and sales of genetically modified plants and potentially relaxing labeling requirements; this decision, however, allows individual states to ban the cultivation of significantly mo...
Progress
52% Bias Score
Colossal Biosciences Genetically Engineers 'Woolly Mice,' Advancing 'De-Extinction' Technology
Colossal Biosciences successfully created mice with long, thick, woolly hair by simultaneously editing seven genes, showcasing a technological advance in precision gene-editing with potential applications in conservation and medicine, despite ethical concerns regarding its application to endangered ...
Colossal Biosciences Genetically Engineers 'Woolly Mice,' Advancing 'De-Extinction' Technology
Colossal Biosciences successfully created mice with long, thick, woolly hair by simultaneously editing seven genes, showcasing a technological advance in precision gene-editing with potential applications in conservation and medicine, despite ethical concerns regarding its application to endangered ...
Progress
56% Bias Score
Netri Opens Organ-on-a-Chip Production Facility
Netri, a French startup, opened a new facility on February 4th producing palm-sized microfluidic devices that mimic organ function using porous silicone and a robotic incubator to culture cells and establish neural connections.
Netri Opens Organ-on-a-Chip Production Facility
Netri, a French startup, opened a new facility on February 4th producing palm-sized microfluidic devices that mimic organ function using porous silicone and a robotic incubator to culture cells and establish neural connections.
Progress
32% Bias Score
"Gene Therapy Breakthrough: Cell-Free Production Method Receives $5.2 Million in Funding"
"Moorfields Eye Hospital successfully used gene therapy to save the sight of four children with a rare blinding genetic condition; this success highlights the potential of Fuse Vectors, a Danish biotech startup, which just secured $5.2 million in funding to revolutionize gene therapy manufacturing t...
"Gene Therapy Breakthrough: Cell-Free Production Method Receives $5.2 Million in Funding"
"Moorfields Eye Hospital successfully used gene therapy to save the sight of four children with a rare blinding genetic condition; this success highlights the potential of Fuse Vectors, a Danish biotech startup, which just secured $5.2 million in funding to revolutionize gene therapy manufacturing t...
Progress
52% Bias Score
Showing 49 to 60 of 92 results